Literature DB >> 24016676

Cardiac ¹⁸F-fluorodeoxyglucose uptake on positron emission tomography after thoracic stereotactic body radiation therapy.

Jaden D Evans1, Daniel R Gomez, Joe Y Chang, Gregory W Gladish, Jeremy J Erasmus, Neal Rebueno, Jose Banchs, Ritsuko Komaki, James W Welsh.   

Abstract

BACKGROUND AND
PURPOSE: Previous studies have shown that increased cardiac uptake of (18)F-fluorodeoxyglucose (FDG) on positron emission tomography (PET) may be an indicator of myocardial injury after radiotherapy. We reviewed patients treated with thoracic stereotactic body radiation therapy (SBRT) and established correlations between SBRT dose and observed changes in cardiac FDG-PET uptake.
MATERIAL AND METHODS: Retrospective analysis identified 39 patients that were treated with SBRT for lung tumors close to the heart. Patients were grouped according to whether or not they had changes in cardiac FDG-PET uptake within the planned SBRT field.
RESULTS: At a median follow-up interval of 39 months (range, 6-81 months), nine patients (23%) showed increased cardiac FDG uptake associated with the heart V₂₀. Of the 19 patients who received 20 Gy to ≥5 cm(3) of the heart, nine (47%) developed increased FDG uptake (vs. 0% for the 20 patients who received 20 Gy to <5 cm(3)) (P=0.0004), all within the 20-Gy isodose line. Patients with hypercholesterolemia prior to SBRT were also more likely to show increased cardiac FDG uptake (P=0.0190).
CONCLUSION: Increased FDG uptake in the heart after SBRT was observed when the 20 Gy isodose line exceeded 5 cm(3) of the heart.
Copyright © 2013 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  FDG–PET; Heart; Radiation toxicity; SABR; SBRT

Mesh:

Substances:

Year:  2013        PMID: 24016676     DOI: 10.1016/j.radonc.2013.07.021

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN: 0167-8140            Impact factor:   6.280


  12 in total

1.  Cardiac Dose and Survival After Stereotactic Body Radiotherapy for Early-stage Non-Small-cell Lung Cancer.

Authors:  Amode R Tembhekar; Cari L Wright; Megan E Daly
Journal:  Clin Lung Cancer       Date:  2016-12-22       Impact factor: 4.785

2.  Evaluating Positron Emission Tomography-Based Functional Imaging Changes in the Heart After Chemo-Radiation for Patients With Lung Cancer.

Authors:  Yevgeniy Vinogradskiy; Quentin Diot; Bernard Jones; Richard Castillo; Edward Castillo; Jennifer Kwak; Daniel Bowles; Inga Grills; Nicholas Myziuk; Thomas Guerrero; Craig Stevens; Tracey Schefter; Laurie E Gaspar; Brian Kavanagh; Moyed Miften; Chad Rusthoven
Journal:  Int J Radiat Oncol Biol Phys       Date:  2020-01-23       Impact factor: 7.038

Review 3.  Specific toxicity after stereotactic body radiation therapy to the central chest : A comprehensive review.

Authors:  Feras Oskan; Gerd Becker; Martin Bleif
Journal:  Strahlenther Onkol       Date:  2016-11-03       Impact factor: 3.621

Review 4.  Precision Cardio-Oncology.

Authors:  Alexandra D Dreyfuss; Paco E Bravo; Constantinos Koumenis; Bonnie Ky
Journal:  J Nucl Med       Date:  2019-01-17       Impact factor: 10.057

5.  Prediction of cardiac events following concurrent chemoradiation therapy for non-small-cell lung cancer using FDG PET.

Authors:  Sang-Geon Cho; Yong-Hyub Kim; Hyukjin Park; Ki Seong Park; Jahae Kim; Sung-Ja Ahn; Hee-Seung Bom
Journal:  Ann Nucl Med       Date:  2022-02-17       Impact factor: 2.258

6.  Quantification of Myocardial Dosimetry and Glucose Metabolism Using a 17-Segment Model of the Left Ventricle in Esophageal Cancer Patients Receiving Radiotherapy.

Authors:  Xue Sha; Guanzhong Gong; Chunlei Han; Qingtao Qiu; Yong Yin
Journal:  Front Oncol       Date:  2020-08-11       Impact factor: 6.244

Review 7.  Cardiovascular imaging in cardio-oncology.

Authors:  Amir Abbas Mahabadi; Christoph Rischpler
Journal:  J Thorac Dis       Date:  2018-12       Impact factor: 2.895

8.  A case report and review of the literature: cardiotoxicities after radiotherapy for breast cancer patients with high-risk factors of cardiovascular disease.

Authors:  Liuwei Tang; Haruo Matsushita; Yojiro Ishikawa; Takanori Ishida; Keiichi Jingu
Journal:  Int Cancer Conf J       Date:  2019-10-08

Review 9.  Series of myocardial FDG uptake requiring considerations of myocardial abnormalities in FDG-PET/CT.

Authors:  Ryogo Minamimoto
Journal:  Jpn J Radiol       Date:  2021-01-31       Impact factor: 2.374

10.  Effect of long fasting on myocardial accumulation in 18F-fluorodeoxyglucose positron emission tomography after chemoradiotherapy for esophageal carcinoma.

Authors:  Yuichi Ishida; Katsuyuki Sakanaka; Satoshi Itasaka; Yuji Nakamoto; Kaori Togashi; Takashi Mizowaki; Masahiro Hiraoka
Journal:  J Radiat Res       Date:  2018-03-01       Impact factor: 2.724

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.